Reference Source

ZAHIDI PHARMACEUTICAL PVT LTD

For ZAHIDI PHARMACEUTICAL PVT LTD, import alert is 54-16; import alert name is "DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS THAT ARE MARKETED AS FOODS, INCLUDING PRODUCTS MARKETED AS DIETARY SUPPLEMENTS, THAT CONTAIN AN ACTIVE PHARMACEUTICAL INGREDIENT"; country is INDIA; address is Ldt J-1601/10 3rd Phase , Gujarat, INDIA; date published is 10/03/2025, verified against its source on 2026-08-06.

Firm
ZAHIDI PHARMACEUTICAL PVT LTD verified
Import alert
54-16 verified
Import alert name
"DETENTION WITHOUT PHYSICAL EXAMINATION OF PRODUCTS THAT ARE MARKETED AS FOODS, INCLUDING PRODUCTS MARKETED AS DIETARY SUPPLEMENTS, THAT CONTAIN AN ACTIVE PHARMACEUTICAL INGREDIENT" verified
Country
INDIA verified
Address
Ldt J-1601/10 3rd Phase , Gujarat, INDIA verified
Date published
10/03/2025 verified
Product code
54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 61 X - - -- A-Histaminic | 66 V - - 99 Miscellaneous Patent Medicines, Etc. verified
Product
Zahidi vita Plus | Zahidi vita Plus | Zahidi vita Plus verified
FDA notes
Product contains Cyproheptadine per FDA analysis | Product contains Cyproheptadine per FDA analysis | Product contains Cyproheptadine per FDA analysis verified
Sourceaccessdata.fda.gov
Verified2026-08-06
Review by2026-10-05
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

ZAHIDI PHARMACEUTICAL PVT LTD Date Published : 10/03/2025 Ldt J-1601/10 3rd Phase , Gujarat, INDIA 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 10/03/2025 Desc: Zahidi vita Plus Notes: Product contains Cyproheptadine per FDA analysis 61 X - - -- A-Histaminic Date Published: 10/03/2025 Desc: Zahidi vita Plus Notes: Product contains Cyproheptadine per FDA analysis 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 10/03/2025 Desc: Zahidi vita Plus Notes: Product contains Cyproheptadine per FDA analysis

— accessdata.fda.gov, retrieved 2026-08-06

Source

Last verified against source: 2026-08-06. Due for re-check by 2026-10-05. This page as Markdown · OKF bundle · full dataset as JSON.